Third consensus on medical treatment of metastatic breast cancer
- PMID: 19608616
- DOI: 10.1093/annonc/mdp261
Third consensus on medical treatment of metastatic breast cancer
Abstract
Background: Treatment options for patients with metastatic breast cancer (MBC) include a rapidly expanding repertoire of medical, surgical and supportive care measures.
Design: To provide timely and evidence-based recommendations for the diagnostic workup and treatment of patients with MBC, an international expert panel reviewed and discussed the evidence available from clinical trials regarding diagnostic, therapeutic and supportive measures with emphasis on their impact on the quality of life and overall survival of patients with MBC.
Results: Evidence-based recommendations for the diagnostic workup, endocrine therapy, chemotherapy, use of targeted therapies and bisphosphonates, surgical treatment and supportive care measures in the management of patients with MBC were formulated.
Conclusions: The present consensus manuscript updates evidence-based recommendations for state-of-the-art treatment of MBC depending on disease-associated and biological variables.
Comment in
-
Third consensus on medical treatment of metastatic breast cancer.Ann Oncol. 2010 Mar;21(3):665; author reply 655-6. doi: 10.1093/annonc/mdp556. Epub 2009 Nov 30. Ann Oncol. 2010. PMID: 19951952 No abstract available.
Similar articles
-
Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer.Breast Cancer Res Treat. 2018 Feb;168(1):159-168. doi: 10.1007/s10549-017-4580-2. Epub 2017 Nov 24. Breast Cancer Res Treat. 2018. PMID: 29177603 Free PMC article.
-
Breast cancer, pregnancy, and breastfeeding.J Obstet Gynaecol Can. 2002 Feb;24(2):164-80; quiz 181-4. J Obstet Gynaecol Can. 2002. PMID: 12196882 English, French.
-
Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology.Lancet Oncol. 2007 Dec;8(12):1101-1115. doi: 10.1016/S1470-2045(07)70378-9. Lancet Oncol. 2007. PMID: 18054880 Review.
-
Third consensus on medical treatment of metastatic breast cancer.Ann Oncol. 2010 Mar;21(3):665; author reply 655-6. doi: 10.1093/annonc/mdp556. Epub 2009 Nov 30. Ann Oncol. 2010. PMID: 19951952 No abstract available.
-
Treatment of metastatic breast cancer: state-of-the-art, subtypes and perspectives.Crit Rev Oncol Hematol. 2011 Dec;80(3):433-49. doi: 10.1016/j.critrevonc.2011.01.010. Epub 2011 Feb 16. Crit Rev Oncol Hematol. 2011. PMID: 21330148 Review.
Cited by
-
Curcumin's effect in advanced and metastatic breast cancer patients treated with first or second-line docetaxel: A randomized trial.Health Sci Rep. 2024 Sep 16;7(9):e70052. doi: 10.1002/hsr2.70052. eCollection 2024 Sep. Health Sci Rep. 2024. PMID: 39286738 Free PMC article.
-
Comprehensive evaluation of the relationship between biomarker profiles and neoadjuvant chemotherapy outcomes for breast cancer patients.Diagn Pathol. 2024 Mar 20;19(1):53. doi: 10.1186/s13000-024-01451-y. Diagn Pathol. 2024. PMID: 38509525 Free PMC article.
-
Impact of high dose radiotherapy for breast tumor in locoregionally uncontrolled stage IV breast cancer: a need for a risk-stratified approach.Radiat Oncol. 2023 Oct 11;18(1):168. doi: 10.1186/s13014-023-02357-7. Radiat Oncol. 2023. PMID: 37821947 Free PMC article. Review.
-
Metastatic breast cancer in Kenya: survival, prognosis and management at a tertiary referral centre.Ecancermedicalscience. 2023 Jun 27;17:1566. doi: 10.3332/ecancer.2023.1566. eCollection 2023. Ecancermedicalscience. 2023. PMID: 37396100 Free PMC article.
-
Palliative care and healthcare utilization among metastatic breast cancer patients in U.S. Hospitals.Sci Rep. 2023 Mar 16;13(1):4358. doi: 10.1038/s41598-023-31404-2. Sci Rep. 2023. PMID: 36928807 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
